Name | Number of supported studies | Average coverage | |
---|---|---|---|
non-classical monocyte | 11 studies | 26% ± 10% | |
macrophage | 9 studies | 25% ± 9% | |
monocyte | 8 studies | 26% ± 7% | |
classical monocyte | 8 studies | 23% ± 8% | |
conventional dendritic cell | 8 studies | 28% ± 9% | |
dendritic cell | 7 studies | 23% ± 7% | |
myeloid cell | 7 studies | 24% ± 8% | |
platelet | 7 studies | 24% ± 8% | |
mononuclear phagocyte | 5 studies | 20% ± 3% | |
mast cell | 4 studies | 28% ± 11% | |
brush cell | 4 studies | 73% ± 18% | |
microglial cell | 4 studies | 19% ± 2% | |
hematopoietic precursor cell | 3 studies | 38% ± 23% | |
intermediate monocyte | 3 studies | 29% ± 9% | |
megakaryocyte | 3 studies | 66% ± 16% | |
megakaryocyte-erythroid progenitor cell | 3 studies | 43% ± 8% |
Insufficient scRNA-seq data for expression of PSTPIP2 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
prostate | 100% | 1265.10 | 245 / 245 | 98% | 10.54 | 490 / 502 |
breast | 99% | 850.87 | 456 / 459 | 98% | 18.72 | 1094 / 1118 |
lung | 100% | 1704.95 | 576 / 578 | 94% | 14.49 | 1088 / 1155 |
bladder | 100% | 649.19 | 21 / 21 | 92% | 12.80 | 464 / 504 |
uterus | 99% | 485.35 | 169 / 170 | 92% | 16.41 | 422 / 459 |
stomach | 100% | 745.96 | 359 / 359 | 90% | 11.61 | 258 / 286 |
intestine | 100% | 666.33 | 965 / 966 | 87% | 10.40 | 461 / 527 |
liver | 99% | 777.39 | 224 / 226 | 86% | 9.24 | 348 / 406 |
esophagus | 99% | 623.10 | 1434 / 1445 | 85% | 13.88 | 156 / 183 |
ovary | 99% | 515.73 | 179 / 180 | 79% | 7.90 | 338 / 430 |
pancreas | 77% | 281.27 | 251 / 328 | 88% | 8.58 | 157 / 178 |
kidney | 90% | 436.66 | 80 / 89 | 74% | 6.05 | 664 / 901 |
skin | 100% | 1077.47 | 1808 / 1809 | 59% | 5.18 | 279 / 472 |
thymus | 91% | 340.79 | 597 / 653 | 61% | 3.91 | 371 / 605 |
adrenal gland | 100% | 662.74 | 258 / 258 | 26% | 1.61 | 59 / 230 |
peripheral blood | 100% | 5145.16 | 929 / 929 | 0% | 0 | 0 / 0 |
spleen | 100% | 9323.64 | 241 / 241 | 0% | 0 | 0 / 0 |
muscle | 100% | 1372.85 | 801 / 803 | 0% | 0 | 0 / 0 |
adipose | 99% | 635.37 | 1195 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 99% | 509.28 | 1315 / 1335 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 96% | 17.50 | 43 / 45 |
lymph node | 0% | 0 | 0 / 0 | 83% | 25.32 | 24 / 29 |
eye | 0% | 0 | 0 / 0 | 70% | 4.72 | 56 / 80 |
heart | 55% | 158.23 | 471 / 861 | 0% | 0 | 0 / 0 |
brain | 16% | 47.40 | 411 / 2642 | 29% | 1.69 | 201 / 705 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0030041 | Biological process | actin filament polymerization |
GO_0005737 | Cellular component | cytoplasm |
GO_0005829 | Cellular component | cytosol |
GO_0005886 | Cellular component | plasma membrane |
GO_0005884 | Cellular component | actin filament |
GO_0051015 | Molecular function | actin filament binding |
Gene name | PSTPIP2 |
Protein name | Proline-serine-threonine phosphatase interacting protein 2 isoform 2 (Proline-serine-threonine phosphatase interacting protein 2, isoform CRA_b) Proline-serine-threonine phosphatase interacting protein 2 isoform 1 Proline-serine-threonine phosphatase interacting protein 2 isoform 3 (Proline-serine-threonine phosphatase interacting protein 2, isoform CRA_a) Proline-serine-threonine phosphatase-interacting protein 2 (PEST phosphatase-interacting protein 2) |
Synonyms | hCG_24029 |
Description | FUNCTION: Binds to F-actin. May be involved in regulation of the actin cytoskeleton (By similarity). . |
Accessions | A0A0S2Z505 A0A0S2Z5F6 ENST00000589328.5 [Q9H939-2] ENST00000409746.5 [Q9H939-1] A0A0S2Z4R2 Q9H939 |